MultiCell Technologies, Inc. (MCET)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Aug 22, 2025, 4:00 PM EDT
MultiCell Technologies Revenue
MultiCell Technologies had revenue of $194.77K in the quarter ending August 31, 2015, with 1,479.79% growth. This brings the company's revenue in the last twelve months to $805.24K, up 1,532.74% year-over-year. In the fiscal year ending November 30, 2014, MultiCell Technologies had annual revenue of $49.32K.
Revenue (ttm)
805.24K
Revenue Growth
+1,532.74%
P/S Ratio
0.01
Revenue / Employee
402.62K
Employees
2
Market Cap
5.00K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2014 | 49.32K | - | - |
| Nov 30, 2013 | 49.32K | - | - |
| Nov 30, 2012 | 49.32K | - | - |
| Nov 30, 2011 | 49.32K | -49.54K | -50.11% |
| Nov 30, 2010 | 98.86K | -75.38K | -43.26% |
| Nov 30, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.09M |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |